Alpha Lipon acid
Showing 26 - 50 of >10,000
Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500
Recruiting
- Pancreas Adenocarcinoma
- CPI-613® (Dose level -1.0 250 mg/m^2)
- +6 more
-
Detroit, Michigan
- +1 more
Nov 9, 2022
Diabetes, Type 2 Trial in Nashville (L-Lysine, Normal Saline)
Enrolling by invitation
- Diabetes Mellitus, Type 2
- L-Lysine
- Normal Saline
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 11, 2022
Antioxidative Stress, End Stage Renal Disease on Dialysis Trial in Cairo (Alpha lipoic acid, Selenium)
Completed
- Antioxidative Stress
- End Stage Renal Disease on Dialysis
- Alpha lipoic acid
- Selenium
-
Cairo, EgyptAin Shams University
Mar 1, 2022
Pompe Disease Infantile-Onset Trial in China (GC301)
Not yet recruiting
- Pompe Disease Infantile-Onset
- GC301
-
Beijing, China
- +4 more
Apr 2, 2023
Breast Cancer, Chemotherapeutic Toxicity Trial in Tanta (Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as
Completed
- Breast Cancer
- Chemotherapeutic Toxicity
- Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
- Placebo Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
-
Tanta, Gharbia, EgyptTanta Oncology Center
Oct 4, 2021
Elevated Blood Sugar Trial (Flaxseed oil capsule, Corn oil capsule)
Not yet recruiting
- Elevated Blood Sugar
- Flaxseed oil capsule
- Corn oil capsule
- (no location specified)
Dec 28, 2021
Healthy Trial (200mg GCE +200mg ALA, 200mg GCE +400mg ALA, 200mg GCE + 200mg DHB)
Not yet recruiting
- Healthy
- 200mg GCE +200mg ALA
- +3 more
- (no location specified)
Nov 13, 2023
Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)
Not yet recruiting
- Burning Mouth Syndrome
- topical placebo tablet
- +5 more
- (no location specified)
Sep 10, 2023
Infantile-onset Pompe Disease Trial in Beijing (Genetic: GC301)
Recruiting
- Infantile-onset Pompe Disease
- Genetic: GC301
-
Beijing, Beijing, ChinaBayi Children's Hospital, Seventh Medical Center, PLA general ho
Sep 30, 2022
Adolescent Migraine Trial in Bhubaneswar (Flunarizine 5mg, Alpha lipoic acid 300mg)
Recruiting
- Adolescent Migraine
- Flunarizine 5mg
- Alpha lipoic acid 300mg
-
Bhubaneswar, Odisha, IndiaAIIMS
Oct 26, 2021
Mucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280) Trial (1. alpha acid lipoic - tables, 2. ozonated oil
Not yet recruiting
- Mucositis (MeSH Unique ID: D052016)
- Stomatitis (MeSH Unique ID: D013280)
- 1. alpha acid lipoic - tables
- +3 more
- (no location specified)
Jan 26, 2022
Healthy Trial in Nashville (Lysine, Controlled Diet)
Enrolling by invitation
- Healthy
- Lysine
- Controlled Diet
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 27, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Cystinuria Trial in San Francisco (Alpha lipoic acid, Placebo)
Active, not recruiting
- Cystinuria
- Alpha lipoic acid
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 31, 2021
Radiation-Induced Mucositis Trial in Cairo (drug, other, radiation)
Not yet recruiting
- Radiation-Induced Mucositis
- Alpha Lipoic Acid 600 MG Oral Tablets
- +2 more
-
Cairo, EgyptAin Shams University
Aug 20, 2021
Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)
Active, not recruiting
- Multiple Sclerosis
- Lipoic acid
- Placebo
-
Birmingham, Alabama
- +10 more
Jan 31, 2023
COVID-19 Trial in Orange (NAC (N-acetyl cysteine) , Alpha lipoic acid (ALA), liposomal glutathione (GSH))
Not yet recruiting
- COVID-19
- NAC (N-acetyl cysteine) , Alpha lipoic acid (ALA), liposomal glutathione (GSH)
-
Orange, CaliforniaUniversity of California Irvine Medical Center
May 10, 2022
Biliary Atresia Trial in Worldwide (OCA 0.1mg, OCA 1.5mg, OCA 5mg)
Active, not recruiting
- Biliary Atresia
- OCA 0.1mg
- +2 more
-
Brussel, Belgium
- +16 more
May 6, 2022
Pompe Disease Trial in Gainesville (genetic, drug, other)
Completed
- Pompe Disease
- Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
- +7 more
-
Gainesville, FloridaClinical and Translational Research Building (CTRB), University
Mar 24, 2022
Diabetic Peripheral Neuropathy Trial in Seoul (Pregabalin 150mg + Alpha-lipoic acid 480mg, Pregabalin 150mg, Alpha-Lipoic Acid
Recruiting
- Diabetic Peripheral Neuropathy
- Pregabalin 150mg + Alpha-lipoic acid 480mg
- +2 more
-
Seoul, Korea, Republic ofInje University Sanggye Paik Hospital
May 26, 2021
Thyroid, Cancer Trial in Seoul (alpha-lipoic acids)
Withdrawn
- Thyroid
- Cancer
- alpha-lipoic acids
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 19, 2021
Exercise Myoglobinuria, Citrulline; Metabolic Disorder, Iron Metabolism Disorders Trial in Gdansk (ALPHA-AMINO ACID DERIVATIVES)
Not yet recruiting
- Exercise Myoglobinuria
- +3 more
- ALPHA-AMINO ACID DERIVATIVES
-
Gdańsk, Pomorskie, Poland
- +1 more
Aug 19, 2022
Acute Aortic Syndrome, Aortic Dissectio Trial in Nanjing, Beijing (Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic
Recruiting
- Acute Aortic Syndrome
- Aortic Dissectio
- Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic Acid-28D-L-Alanine-28E-L-Proline-28F-L-Alanine-28G-L-Asparagine-
- Blank control
-
Nanjing, Jiangsu, China
- +2 more
Sep 25, 2022
Non-Alcoholic Fatty Liver Disease Trial in Bhubaneswar (Placebo, Alphalipoic acid)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Placebo
- Alphalipoic acid
-
Bhubaneswar, Odisha, IndiaAIIMS
Jul 5, 2021